We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PBLA market cap is 5.39M. The company's latest EPS is USD -5.2037 and P/E is -0.21.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.89M | -7.86M | -7.04M | -6.73M | -8.1M |
| Net Income | -5.84M | -7.84M | -6.47M | -7.12M | -7.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.32M | -5.75M | -10.01M | -34.09M | -25.65M |
| Net Income | -6.2M | -4.77M | -10.14M | -34.93M | -25.26M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.55M | 10.63M | 11.8M | 10.53M | 9.41M |
| Total Liabilities | 14.75M | 13.11M | 16.51M | 13.71M | 19.98M |
| Total Equity | 4.8M | -2.48M | -4.71M | -3.19M | -10.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.14M | 9.81M | 12.87M | 4.98M | 11.8M |
| Total Liabilities | 1.76M | 1.37M | 2.66M | 13.03M | 16.51M |
| Total Equity | 1.39M | 8.45M | 10.21M | -8.05M | -4.71M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.49M | -22.17M | -25.25M | -9.39M | -10.37M |
| Investing | N/A | 400k | 400k | N/A | 775k |
| Financing | 21.41M | 21.39M | 26.14M | 7.08M | 7.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.74M | -3.85M | -6.7M | -15.28M | -25.25M |
| Investing | N/A | N/A | -540k | -656k | 400k |
| Financing | 3.78M | 10.44M | 10.1M | 5.35M | 26.14M |
| Market Cap | 5.39M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.09 |
| Price to Book Ratio | -1.14 |
| Dividend Yield | - |
| Shares Outstanding | 4.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (0.88%) |
| Company Name | Panbela Therapeutics Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
